Carlos Lorenzo1, Andreas Festa2, Anthony J Hanley3,4, Marian J Rewers5, Agustin Escalante1, Steven M Haffner1. 1. Department of Medicine, University of Texas Health Science Center, San Antonio, TX. 2. Eli Lilly and Company, Vienna, Austria andreasfesta@icloud.com. 3. Department of Nutritional Sciences and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 4. Leadership Sinai Centre for Diabetes, Mt. Sinai Hospital, Toronto, Ontario, Canada. 5. Barbara Davis Center for Diabetes, University Colorado School of Medicine, Aurora, CO.
Abstract
OBJECTIVE: N-acetylglucosamine/galactosamine (GlycA) and sialic acid (GlycB) moieties of glycosylated serum proteins are nonspecific measures of inflammation, but conclusive data on their relationship with insulin resistance or insulin secretion are missing. Therefore, we aimed to examine the relation of GlycA, GlycB, and C-reactive protein (CRP) to direct measures of insulin sensitivity (insulin sensitivity index [SI]) and insulin secretion (acute insulin response [AIR]). RESEARCH DESIGN AND METHODS: This study used cross-sectional analyses and included 1,225 participants with and without type 2 diabetes in the Insulin Resistance Atherosclerosis Study (IRAS). SI and AIR were measured using the frequently sampled intravenous glucose tolerance test, and GlycA and GlycB were measured using nuclear magnetic resonance spectroscopy. RESULTS: GlycA and GlycB had a strong correlation with CRP (r = 0.60 [P < 0.001] and r = 0.46 [P < 0.001], respectively). In a linear regression model with both GlycA and CRP as independent variables, GlycA (β × 1 SD, -0.04 ± 0.02; P < 0.01) and CRP (-0.06 ± 0.02; P < 0.001) were independently associated with SI even after adjusting for demographics, smoking, physical activity, plasma glucose, and BMI. However, neither CRP nor GlycA had an independent relationship with AIR. CONCLUSIONS: GlycA may complement CRP in evaluating the relationship between inflammation, glucose tolerance, and insulin resistance.
OBJECTIVE:N-acetylglucosamine/galactosamine (GlycA) and sialic acid (GlycB) moieties of glycosylated serum proteins are nonspecific measures of inflammation, but conclusive data on their relationship with insulin resistance or insulin secretion are missing. Therefore, we aimed to examine the relation of GlycA, GlycB, and C-reactive protein (CRP) to direct measures of insulin sensitivity (insulin sensitivity index [SI]) and insulin secretion (acute insulin response [AIR]). RESEARCH DESIGN AND METHODS: This study used cross-sectional analyses and included 1,225 participants with and without type 2 diabetes in the Insulin Resistance Atherosclerosis Study (IRAS). SI and AIR were measured using the frequently sampled intravenous glucose tolerance test, and GlycA and GlycB were measured using nuclear magnetic resonance spectroscopy. RESULTS:GlycA and GlycB had a strong correlation with CRP (r = 0.60 [P < 0.001] and r = 0.46 [P < 0.001], respectively). In a linear regression model with both GlycA and CRP as independent variables, GlycA (β × 1 SD, -0.04 ± 0.02; P < 0.01) and CRP (-0.06 ± 0.02; P < 0.001) were independently associated with SI even after adjusting for demographics, smoking, physical activity, plasma glucose, and BMI. However, neither CRP nor GlycA had an independent relationship with AIR. CONCLUSIONS:GlycA may complement CRP in evaluating the relationship between inflammation, glucose tolerance, and insulin resistance.
Authors: James D Otvos; Irina Shalaurova; Justyna Wolak-Dinsmore; Margery A Connelly; Rachel H Mackey; James H Stein; Russell P Tracy Journal: Clin Chem Date: 2015-03-16 Impact factor: 8.327
Authors: Armin Imhof; Margit Fröhlich; Hannelore Loewel; Nicole Helbecque; Mark Woodward; Phillipe Amouyel; Gordon D O Lowe; Wolfgang Koenig Journal: Clin Chem Date: 2003-04 Impact factor: 8.327
Authors: Jacob L Barber; William E Kraus; Timothy S Church; James M Hagberg; Paul D Thompson; David B Bartlett; Michael W Beets; Conrad P Earnest; Kim M Huffman; Rian Q Landers-Ramos; Arthur S Leon; D C Rao; Richard L Seip; James S Skinner; Cris A Slentz; Kenneth R Wilund; Claude Bouchard; Mark A Sarzynski Journal: Atherosclerosis Date: 2018-07-26 Impact factor: 5.162
Authors: Jordan A Levine; Jung Min Han; Anna Wolska; Sierra R Wilson; Tushar P Patel; Alan T Remaley; Vipul Periwal; Jack A Yanovski; Andrew P Demidowich Journal: J Clin Lipidol Date: 2020-08-04 Impact factor: 4.766
Authors: Maria Fizelova; Raimo Jauhiainen; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Johanna Kuusisto; Markku Laakso; Alena Stancáková Journal: J Clin Endocrinol Metab Date: 2017-09-01 Impact factor: 5.958
Authors: David B Bartlett; Cris A Slentz; Margery A Connelly; Lucy W Piner; Leslie H Willis; Lori A Bateman; Esther O Granville; Connie W Bales; Kim M Huffman; William E Kraus Journal: Oxid Med Cell Longev Date: 2017-05-31 Impact factor: 6.543
Authors: Margery A Connelly; James D Otvos; Irina Shalaurova; Martin P Playford; Nehal N Mehta Journal: J Transl Med Date: 2017-10-27 Impact factor: 5.531
Authors: Jun He; Feiyun Ouyang; Dan Qiu; Yanying Duan; Dan Luo; Shuiyuan Xiao Journal: Int J Environ Res Public Health Date: 2020-06-15 Impact factor: 3.390